Indian Pharma's future success depends on stringent quality control measures
Healthcare Radius|September 2022
Spurious drugs have become a serious issue worldwide, especially in India. According to USTR estimates nearly 20 percent of the drugs sold in India are counterfeit. Learn the steps that India must take to battle this menace and thus protect its image in the global pharmaceutical market
MS. ARUSHI JAIN
Indian Pharma's future success depends on stringent quality control measures

India has always been in the eye of the storm when it comes to the country's mounting spurious medicine problem. Even the US Trade Representative (USTR) has scrutinized Indian pharmaceutical companies over this issue since according to its report, approximately 20 percent of all drugs on sale in our market are counterfeit. And this is the kind of study that can adversely affect India's budding market and reputation, even as it ranks third in the world in terms of volume. India fulfills over 20 percent of the global demand for generic drugs, which is no surprise because we have over 10,500 manufacturing units and 3,000 firms across the country.

But the fact remains that if the industry does not invest correctly in the short term, India may fall behind in the race due to a sheer lack of quality products. To regain our status in the world pharma rankings, the Indian industry will have to take certain measures such as encouraging innovation through augmented spending on R&D, making marketing companies also accountable for product quality, and implementing more stringent quality control (QC).

Following are some more factors implementing which can directly result in improving the quality of Indian drugs and ensuring they are of the best quality going forward:

API quality check

Esta historia es de la edición September 2022 de Healthcare Radius.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

Esta historia es de la edición September 2022 de Healthcare Radius.

Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.

MÁS HISTORIAS DE HEALTHCARE RADIUSVer todo
KIMSHEALTH launches electrophysiology lab with 3D mapping
Healthcare Radius

KIMSHEALTH launches electrophysiology lab with 3D mapping

'ENSITE X' is the first of its kind in Kerala and the third in India enabling precise identification, mapping, and targeting the abnormal electrical activities in the heart.

time-read
1 min  |
November 2024
Molbio boosts Goa's healthcare system with CSR initiatives
Healthcare Radius

Molbio boosts Goa's healthcare system with CSR initiatives

The company has donated four state-of-the-art Advanced Life Support (ALS) ambulances and two hearse vans for National Highway emergencies

time-read
1 min  |
November 2024
USV introduces affordable heart failure medication
Healthcare Radius

USV introduces affordable heart failure medication

This cost-effective option addresses the rising cases of heart failure in India, offering lifesaving care to millions of patients who need it the most.

time-read
1 min  |
November 2024
City Imaging & Clinical Labs to expand services to 50 hospitals
Healthcare Radius

City Imaging & Clinical Labs to expand services to 50 hospitals

The company is currently associated with 10 hospitals, providing comprehensive lab management services, including 24/7 in-house phlebotomy and lab testing.

time-read
1 min  |
November 2024
Oncare raises $1 million in seed funding, to set up 10 units
Healthcare Radius

Oncare raises $1 million in seed funding, to set up 10 units

Oncare has raised $1 million in a seed funding round led by Huddle Ventures. It plans to deploy the raised capital to expand its operations to 10 new centers.

time-read
1 min  |
November 2024
Nutrabay forays into Ayurvedic supplements market with Shilajit
Healthcare Radius

Nutrabay forays into Ayurvedic supplements market with Shilajit

Nutrabay's aims at gaining market share from the existing ayurveda supplements market with a distinctive product proposition and education about the benefits of Shilajit.

time-read
1 min  |
November 2024
INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY
Healthcare Radius

INDIA'S PREPAREDNESS ON HEALTHCARE-ASSOCIATED INFECTIONS: A GROWING FOCUS ON PATIENT SAFETY

The country's diverse healthcare landscape necessitates a flexible and multifaceted approach to infection control that can be adapted to various settings and resource levels.

time-read
8 minutos  |
November 2024
TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES
Healthcare Radius

TRANSFORMING CARDIAC SURGERY: HOW AI IS REVOLUTIONIZING PATIENT CARE AND OUTCOMES

Dr. Swarup Swaraj Pal shared his insights on the current state and future prospects of AI in cardiac procedures.

time-read
3 minutos  |
November 2024
BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY
Healthcare Radius

BEYOND THE LAB: THE CRITICAL ROLE OF LOGISTICS IN INDIA'S PHARMACEUTICAL INDUSTRY

As India continues to expand its role in the global pharmaceutical market, the importance of a robust, reliable, and innovative logistics infrastructure cannot be overstated.

time-read
8 minutos  |
November 2024
LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION
Healthcare Radius

LIFESTYLE DISEASES IN CHILDREN: A WAKE-UP CALL FOR A HEALTHIER GENERATION

In today's fast-paced world, children face an unexpected enemy: lifestyle diseases. Conditions like obesity, Type 2 diabetes, and hypertension are now affecting our youth. What's causing this shift, and how can we combat it?

time-read
3 minutos  |
November 2024